๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hepatic Artery Chemoembolization for Hepatocellular Carcinoma in Patients Listed for Liver Transplantation

โœ Scribed by Paul H. Hayashi; Michael Ludkowski; Lisa M. Forman; Michael Osgood; Stephen Johnson; Marcelo Kugelmas; James F. Trotter; Thomas Bak; Michael Wachs; Igal Kam; Janette Durham; Gregory T. Everson

Book ID
114803087
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
100 KB
Volume
4
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Preoperative hepatic artery chemoemboliz
Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma
โœ Harnois, Denise M. ;Steers, Jeffery ;Andrews, James C. ;Rubin, Joseph C. ;Pitot, ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 111 KB

In our experience, the primary obstacle precluding the widespread use of orthotopic liver transplantation (OLT) for definitive therapy of hepatocellular carcinoma (HCC), even for early-stage disease, is preventing tumor recurrence. Chemoembolization is an attractive strategy to minimize tumor progre

Liver transplantation for hepatocellular
Liver transplantation for hepatocellular carcinoma: Results with preoperative chemoembolization
โœ Venook, Alan P. ;Ferrell, Linda D. ;Roberts, John P. ;Emond, Jean ;Frye, John W. ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 572 KB

patients who met the following criteria-hepatic tumor unresectable because of location or inadequate liver reserve, no metastases, HBsAg negative, no tumor larger than 5 cm in diameter, and no more than three tumors-were enrolled prospectively in a protocol employing preoperative chemoembolization t

Drop-out rates of patients with hepatoce
Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization
โœ Yamini K. Maddala; Linda Stadheim; James C. Andrews; Lawrence J. Burgart; Charle ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 100 KB ๐Ÿ‘ 1 views

Patients with hepatocellular carcinoma (HCC) are assigned model for end stage liver disease (MELD) scores to provide access to liver transplantation (LT). An equitable policy would equate HCC progression beyond acceptable transplantation criteria with death on the waiting list. However, limited info